Attention deficit/hyperactivity disorder and methylphenidate - A review of height/weight, cardiovascular, and somatic complaint side effects

    Authors

    M. D. Rapport;C. Moffitt

    Comments

    Authors: contact us about adding a copy of your work at STARS@ucf.edu

    Abbreviated Journal Title

    Clin. Psychol. Rev.

    Keywords

    DEFICIT HYPERACTIVITY DISORDER; PLACEBO-CONTROLLED EVALUATION; DOSE-RESPONSE; ADHD CHILDREN; HYPERKINETIC CHILDREN; CLASSROOM; PERFORMANCE; SOCIAL-BEHAVIOR; GROWTH; ADOLESCENTS; BOYS; Psychology, Clinical

    Abstract

    Three classes (height/weight, cardiovascular, and somatic complaints) of treatment emergent symptoms (side effects) associated with methylphenidate (MPH) therapy for children with attention deficit/hyperactivity disorder (ADHD) are reviewed. The more easily quantifiable side effects (e.g., blood pressure [BP], heart rate [HR], height/weight) are mostly transient, dose-dependent, easily rectified with dosage adjustments, and considered minor from a clinical perspective considering the breadth and level of improvement in behavior and cognitive functioning observed in most children. Previously reported somatic complaints associated with psychostimulant therapy may reflect symptoms occurring prior to initiation of treatment and require additional study. (C) 2002 Elsevier Science Ltd. All rights reserved.

    Journal Title

    Clinical Psychology Review

    Volume

    22

    Issue/Number

    8

    Publication Date

    1-1-2002

    Document Type

    Review

    Language

    English

    First Page

    1107

    Last Page

    1131

    WOS Identifier

    WOS:000178946200001

    ISSN

    0272-7358

    Share

    COinS